These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36332985)

  • 1. Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.
    Ly KI; Merker VL; Cai W; Bredella MA; Muzikansky A; Thalheimer RD; Da JL; Orr CC; Herr HP; Morris ME; Chang CY; Harris GJ; Plotkin SR; Jordan JT
    Neurology; 2023 Feb; 100(7):e661-e670. PubMed ID: 36332985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
    Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
    PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
    Attia S; Guirguis M; Le LQ; Chhabra A
    Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.
    Mautner VF; Hartmann M; Kluwe L; Friedrich RE; Fünsterer C
    Neuroradiology; 2006 Mar; 48(3):160-5. PubMed ID: 16432718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics.
    Liu Y; Jordan JT; Bredella MA; Erdin S; Walker JA; Vangel M; Harris GJ; Plotkin SR; Cai W
    Neurology; 2020 Jun; 94(24):e2521-e2531. PubMed ID: 32345730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1.
    Jett K; Nguyen R; Arman D; Birch P; Chohan H; Farschtschi S; Fuensterer C; Kluwe L; Friedman JM; Mautner VF
    Am J Med Genet A; 2015 Jul; 167(7):1518-24. PubMed ID: 25900062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
    Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J
    PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Sonographic Classification of Neurofibromas in Children with Neurofibromatosis Type 1 - A Cluster Analysis.
    García-Martínez FJ; Alfageme F; Duat-Rodríguez A; Andrés Esteban EM; Hernández-Martín A
    Ultraschall Med; 2023 Apr; 44(2):e118-e125. PubMed ID: 34820795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.
    Akshintala S; Baldwin A; Liewehr DJ; Goodwin A; Blakeley JO; Gross AM; Steinberg SM; Dombi E; Widemann BC
    Neuro Oncol; 2020 Sep; 22(9):1368-1378. PubMed ID: 32152628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
    Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
    Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth behavior of plexiform neurofibromas after surgery.
    Nguyen R; Ibrahim C; Friedrich RE; Westphal M; Schuhmann M; Mautner VF
    Genet Med; 2013 Sep; 15(9):691-7. PubMed ID: 23598713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
    Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
    Tsai LL; Drubach L; Fahey F; Irons M; Voss S; Ullrich NJ
    J Neurooncol; 2012 Jul; 108(3):469-75. PubMed ID: 22407214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
    Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
    Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
    BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1.
    Armstrong AE; Rhodes SD; Smith A; Chen S; Bessler W; Ferguson MJ; Jiang L; Li X; Yuan J; Yang X; Yang FC; Robertson KA; Ingram DA; Blakeley JO; Clapp DW
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28372. PubMed ID: 32459399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression.
    Kang E; Kim YM; Choi Y; Lee Y; Kim J; Choi IH; Yoo HW; Yoon HM; Lee BH
    Orphanet J Rare Dis; 2022 Jan; 17(1):24. PubMed ID: 35093157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
    Dombi E; Baldwin A; Marcus LJ; Fisher MJ; Weiss B; Kim A; Whitcomb P; Martin S; Aschbacher-Smith LE; Rizvi TA; Wu J; Ershler R; Wolters P; Therrien J; Glod J; Belasco JB; Schorry E; Brofferio A; Starosta AJ; Gillespie A; Doyle AL; Ratner N; Widemann BC
    N Engl J Med; 2016 Dec; 375(26):2550-2560. PubMed ID: 28029918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
    Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B
    Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.